FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

Sanofi related Press Releases

Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex

Posted February 8, 2012

PARIS & NEW YORK--(BUSINESS WIRE)-- Sanofi (EURONEXT: SAN and NYSE: SNY) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that Apotex has made payment in the amount of $442,209,362 to Read more...

Rib-X Pharmaceuticals Receives $3 Million Milestone Payment from Sanofi in the RX-04 Collaboration

Posted February 7, 2012

Rib-X Pharmaceuticals Receives $3 Million Milestone Payment from Sanofi in the RX-04 Collaboration- Fourth milestone payment in deal to create entirely new classes of antibiotic therapeutics Read more...

Rib-X Pharmaceuticals Receives $3 Million Milestone Payment from Sanofi in the RX-04 Collaboration

Posted February 7, 2012

- Fourth milestone payment in deal to create entirely new classes of antibiotic therapeutics targeting bacterial ribosomes - NEW HAVEN, Conn.--(BUSINESS WIRE)-- Rib-X Pharmaceuticals, Inc. announced Read more...

Genzyme Announces FDA Approval of Framingham Manufacturing Plant

Posted January 24, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the Food and Drug Administration (FDA) has approved its manufacturing plant in Read more...

Genzyme Announces European Approval of Framingham Manufacturing Plant

Posted January 18, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today that the European Medicines Agency (EMA) has approved its manufacturing plant in Read more...

UCSF, Sanofi Collaborate to Find New Diabetes Cures

Posted January 10, 2012

UCSF, Sanofi Collaborate to Find New Diabetes Cures JOINTLY RELEASED BY SANOFI AND THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO SAN FRANCISCO, Jan. 10, 2012 /PRNewswire/ -- The University of Read more...

Foundation Medicine Announces Collaboration with Sanofi

Posted January 10, 2012

Fifth Partnership Will Help Translate Cancer Genomic Science to Clinical Results CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc., a molecular information company that brings Read more...

Third Rock Ventures and Sanofi Announce Launch of Warp Drive Bio; Broad Strategic Partnership Builds Innovative Genomics S

Posted January 10, 2012

Breakthrough Business Model Provides Initial Financing of $125 Million, Fosters Collaboration and Creates Independent, Innovative Biotech Company BOSTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Read more...

Positive results reported by Sanofi for once-daily lixisenatide (Lyxumia 1)) in combination with Lantus? (insulin glargine) in T

Posted December 6, 2011

Positive results reported by Sanofi for once-daily lixisenatide (Lyxumia 1)) in combination with Lantus? (insulin glargine) in Type 2 diabetes -- Data from a Phase III study, GetGoal Duo 1, show that Read more...

Sanofi Reports Positive Results for Once-daily Lyxumia® (lixisenatide) in Combination with Lantus® (insulin glargine) in Type 2

Posted December 6, 2011

Sanofi Reports Positive Results for Once-daily Lyxumia® (lixisenatide) in Combination with Lantus® (insulin glargine) in Type 2 Diabetes - Data from phase III GetGoal Duo 1 study show Read more...
12345678next ›last »